Suicidality in pediatric patients treated with antidepressant drugs.
about
Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescentsTricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescentsPolyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescentsPsychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescentsNewer generation antidepressants for depressive disorders in children and adolescentsCombined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD)Fluvoxamine versus other anti-depressive agents for depressionPharmacotherapy for anxiety disorders in children and adolescentsSelective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescentsComparative safety of antidepressant agents for children and adolescents regarding suicidal actsHypokalemia secondary to bupropion sustained release overdosePredictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) studyAnimal models of suicide-trait-related behaviorsEffectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trialsRisk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug AdministrationVenlafaxine for major depressionRisk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort studyThe role of inflammation in suicidal behaviourGeneralised anxiety disorderAppraisal of the methodological quality and summary of the findings of systematic reviews on the relationship between SSRIs and suicidalitySuicidality associated with antiepileptic drugs: implications for the treatment of neuropathic pain and fibromyalgiaThe characterization, current medications, and promising therapeutics targets for premature ejaculationLevomilnacipran for the treatment of major depressive disorder: a reviewPharmacotherapy in depressed children and adolescentsIncreased response to a 5-HT challenge after discontinuation of chronic serotonin uptake inhibition in the adult and adolescent rat brainSelective Serotonin Reuptake Inhibitors and Violent Crime: A Cohort StudyAntidepressant Utilization and Suicide in Europe: An Ecological Multi-National StudyFluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat.Paradoxical anxiogenic response of juvenile mice to fluoxetineEffects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind, placebo-controlled trialsOmega-3 fatty acid deficient male rats exhibit abnormal behavioral activation in the forced swim test following chronic fluoxetine treatment: association with altered 5-HT1A and alpha2A adrenergic receptor expression.Transient postnatal fluoxetine leads to decreased brain arachidonic acid metabolism and cytochrome P450 4A in adult miceMeta-analysis of clinical trial safety data in a drug development program: answers to frequently asked questions.Generalizing from clinical trial data: a case study. The risk of suicidality among pediatric antidepressant usersMetareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice.Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.Generalised anxiety disorder.Antidepressants and suicide in adolescents and adults: a public health experiment with unintended consequences?Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' dataSafety and tolerability of desvenlafaxine in children and adolescents with major depressive disorder.
P2860
Q24187748-B23A2973-D08E-485B-AAC4-CE6EE4474CC6Q24193517-3BF67E42-C1DA-447F-94B2-59693BEA41A8Q24202221-6E2EB65F-F665-412D-8352-9B1AF0B2A8BFQ24202831-E63B62C5-4722-4994-9EBF-1ADB3A0F4965Q24202873-8F7A98E9-F0D9-4789-805A-E47B4C3F09CAQ24234332-4AA85D68-DBE7-497D-BA02-91826C5BE0F2Q24236814-12D45E87-E06F-4500-BE91-E1AF1EA54AA1Q24239941-3F7CA861-09A6-4DEB-9404-670F0D98ADB0Q24244127-97B9B590-B765-4790-A3FD-063729582503Q24594810-86F0B879-8BC0-4C87-8453-4CBA5CBCA364Q24597202-3BC475AB-3DAC-4329-81BD-CFE20EA97AA6Q24607463-1A599E45-E43C-409F-B56E-9EECCE9E3708Q24645693-0B78EA31-D7A8-4465-AB75-CF3C442FFFDFQ24648108-DED886CD-36F5-4892-8035-15101D38119BQ24653558-12540B9E-3E2E-4A3C-BD72-71747D3D959DQ24678849-A4313565-A7AA-4E57-80FC-334FD21AF512Q24678875-56FB543B-EAA8-46E0-A1AF-A9849B9D99F6Q26800426-36D4064E-EE59-4FFC-9A70-FBE95FCF19A2Q26863288-6AD18F9A-0C64-4ED2-BE4C-2134AD20FDC4Q26864343-2F3558E5-C726-411E-AAF4-AF740DE72498Q27009981-C78DFDB6-19D4-4D5E-94BB-DCCCF5CB2812Q28081739-E51FA268-3D02-4565-AF83-911D26F09070Q28083216-3EB89184-CC4B-46FC-AC8A-3F3474578170Q28247623-13D28B36-0982-4A38-88A6-E20491A4469BQ28539770-721E9ACB-A520-48DD-93EB-3EC17A1F3B50Q28548023-F1D43FA0-BD90-4EE0-83CD-B4CB0D52644BQ28681287-A44F67C4-E490-49A8-A444-C76FC75BAE44Q30477109-0049EDC9-00E0-45D7-8010-5E44BC35E399Q30491364-DCC71272-D641-4C94-8277-9736FEE045A6Q30491758-1AE5EF98-10D8-4927-ABB3-7B3734D21FB0Q30569788-5D8D5DF0-EFB8-4B2F-8D24-A393D44E7FE4Q30575789-C392E89E-7E15-4E12-AC01-58B764631783Q30578166-B2363229-B423-4321-84EE-B38148090A84Q31151227-E99AA9A5-8D5D-4983-8F42-2E14F2DBA0E8Q33303429-83FA712E-C77D-460C-A1A3-78513ACC5226Q33350235-9B8E3FC6-732F-4329-89E8-0B3AFC2C6201Q33446789-B06C5457-D1E2-48C9-BFEE-51E22D13B6B0Q33561411-4B8337C0-F8C2-40F2-84C3-5FC7F56DA342Q33571327-10DEC320-FC52-4D28-970E-1B69353F8BE2Q33632399-1575D15C-E0DB-4276-B12C-1F19FB7DE145
P2860
Suicidality in pediatric patients treated with antidepressant drugs.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Suicidality in pediatric patients treated with antidepressant drugs.
@en
Suicidality in pediatric patients treated with antidepressant drugs.
@nl
type
label
Suicidality in pediatric patients treated with antidepressant drugs.
@en
Suicidality in pediatric patients treated with antidepressant drugs.
@nl
prefLabel
Suicidality in pediatric patients treated with antidepressant drugs.
@en
Suicidality in pediatric patients treated with antidepressant drugs.
@nl
P2093
P921
P1433
P1476
Suicidality in pediatric patients treated with antidepressant drugs.
@en
P2093
Judith Racoosin
Tarek A Hammad
Thomas Laughren
P304
P356
10.1001/ARCHPSYC.63.3.332
P407
P577
2006-03-01T00:00:00Z